NEW YORK (
CHANGE IN RATINGS, EPS
Ariad Pharmaceuticals (ARIA) is upgraded to hold at TheStreet Ratings. Agrium (AGU) estimates and target were reduced at Goldman Sachs. Shares of AGU are now seen reaching $86. Estimates were also cut, given lower realized margins, Goldman said. Neutral rating.
Amphenol (APH) was downgraded at Ticonderoga from Neutral to Sell. Valuation call, based on a $38 price target, Ticonderoga said.
Ann Taylor (ANN) numbers were increased at UBS. Shares are now seen reaching $33. Estimates were also increased on strong sales and margin gains at LOFT, e-commerce and outlets, UBS said. Buy rating.
Archer-Daniels (ADM) was initiated with a Neutral rating at Ticonderoga. The company is trading at book value, but lacks near-term catalysts, Ticonderoga said.Brocade's (BRCD) target was raised at ThinkEquity. Shares are now seen reaching $6, according to ThinkEquity. Company is carrying a lot of momentum into 2012, ThinkEquity said. Buy rating. CBOE Holdings (CBOE) estimates were raised at Oppenheimer through 2012. Exceptional market volatility drove an exceptional quarter, Oppenheimer said. Maintain $29 price target and Outperform rating. Church & Dwight (CHD) numbers were increased at Jefferies. Estimates were raised through 2012. Company is positioned well for a slow-growth environment, Jefferies said. Hold rating and new $43 price target. Church & Dwight estimates were lowered through 2012 at UBS. Some noise, but a generally in-line quarter, UBS said. Maintain $44 price target and Neutral rating. Clean Harbors (CLH) numbers were increased at Goldman Sachs. Estimates were raised through 2013. Company is seeing higher sales, Goldman said. Neutral rating and new $57 price target. CME (CME) target was boosted at Jefferies. Shares are now seen reaching $315. Core business trends are picking up, Jefferies said. Buy rating. Comcast (CMCSA) estimates, target were cut at Morgan Stanley. Shares are now seen reaching $27. Estimates were also reduced, given lower expected results at NBC Universal, Morgan Stanley said. Equal-weight rating. Consolidated Edison (ED) numbers were boosted at Goldman Sachs. Shares are now seen reaching $52. Estimates were also increased, given a better outlook for the company's nonregulated assets, Goldman said. Sell rating. Con-Way (CNW) estimates were lowered at Sterne Agee through 2012. Pension and 401(k) headwinds, Sterne Agee said. Maintain Buy rating and $48 price target.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV